Treace Medical Concepts Inc. (TMCI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Treace Medical Concepts I...

    NASDAQ: TMCI · Real-Time Price · USD
    6.66
    -0.02 (-0.30%)
    At close: Sep 26, 2025, 3:59 PM
    6.66
    0.00%
    After-hours: Sep 26, 2025, 04:04 PM EDT

    Treace Medical Concepts Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 209.36M 187.12M 141.84M 94.42M
    Cost of Revenue
    		 41.09M 35.18M 27.52M 17.83M
    Gross Profit
    		 168.26M 151.94M 114.31M 76.59M
    Operating Income
    		 -55.69M -51.43M -34.84M -16.51M
    Interest Income
    		 4.88M 6.73M 1.31M 18K
    Pretax Income
    		 -55.74M -49.53M -42.81M -20.55M
    Net Income
    		 -55.74M -49.53M -42.81M -20.55M
    Selling & General & Admin
    		 203.36M 187.93M 137.57M 83.84M
    Research & Development
    		 20.59M 15.44M 13.58M 10.2M
    Other Expenses
    		 n/a n/a -1.99M -938K
    Operating Expenses
    		 223.95M 203.37M 149.16M 93.1M
    Interest Expense
    		 5.26M 5.17M 4.4M 4.06M
    Selling & Marketing Expenses
    		 147.64M 140.89M 104.57M 65.41M
    Cost & Expenses
    		 265.05M 238.55M 176.68M 110.93M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 62.11M 60.85M 55.28M 54.18M
    Shares Outstanding (Diluted)
    		 62.11M 60.85M 55.28M 54.18M
    EPS (Basic)
    		 -0.9 -0.81 -0.77 -0.38
    EPS (Diluted)
    		 -0.9 -0.81 -0.77 -0.38
    EBITDA
    		 -42.07M -39.01M -36.28M -15.81M
    EBIT
    		 -50.49M -44.36M -38.42M -16.49M
    Depreciation & Amortization
    		 8.42M 5.35M 2.13M 685K

    Add to Watchlist